Friday, 18 Oct 2019

You are here

My ACR Takeaways

With ACR 2017 winding down and the sheer volume of information seemingly overwhelming, I wanted to take the time to write an article regarding a few tips I learned that I will use in clinical practice. 

1. With regards to the flu vaccine, holding MTX for two weeks after the flu vaccine will increase immunogenicity without worsening disease. 
2. CAPS is a complementopathy and Eculizumab (anti-C5a) is approved for treatment, though is expensive
3. 1% of GPA patients can present with pituitary involvement and respond to Cytoxan or Rituxan
4. HCQ should be a mainstay in APS therapy – can reduce size of thrombus and number of potential events. 
5. MMF at 3 grams is not superior to 2 grams in rheum-related ILD
6. RA and SpA remission patients fare better with continued therapy than with withdrawal 
7. A healthy mom is the best thing for a healthy baby in terms of safety of continuing DMARDs and bDMARDs during pregnancy and lactation. 
8. Options for MACRA and MIPs data submission supported by ACR include the RISE registry and RCR

While this list barely scratches the surface, it’s a helpful start to digesting data from ACR to use for our day to day practice. I’m looking forward to hearing more about upcoming guidelines, updated diagnostic criteria, telemedicine, and US advances in both the education and diagnostic realms. 

Until Chicago!

 


Rheumatologists' Comments

Dear Rachel Tate, it´s a fantastic compilation of the ACR on what we should start (or keep) doing. Congratulations, Carlos Antonio Moura

More Like This

RheumNow Podcast – Fight or Switching (DMARDs) (10.18.19)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – When You’re Hot You’re Hot (10.11.19)

Dr. Jack Cush delivers select commentary on select news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – Women Take Over Rheumatology (10.4.19)

Dr. Jack Cush reviews the News and Journal Reports from this week on RheumNow.com.

Increasingly Women are Choosing Subspecialty Careers

JAMA Internal Medicine has an analysis of the growing trend of more women enrolling in medical schools in the last few decades, such that more than half of US Med school matriculants in 2017 were women.  Also in 2017, 42% of residents in internal medicine were women.  The reported analysis looked at internal medicine subspecialty choices by women and men between 1991 to 2016.

 

RheumNow Podcast – Cancer Risk in Systemic Sclerosis (9.27.19)

Dr. Jack Cush reviews the news and articles from the past week on RheumNow.com.